CS First Boston Cuts Applera-Applied Biosystems Rating

Analyst Meirav Chovav doesn't think the maker of biotech instruments will meet its targets, and says foreign currency troubles will likely hurt near-term growth

CS First Boston downgraded Applera-Applied Biosystems (ABI ) to hold from buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.